Patient Safety in Compound Therapies: Understanding Certificates of Analysis for Compounded GLP-1s

Medically Reviewed by

Jaclyn P. Leyson-Azuela, RMT, MD, MPH

DoctorAdam Medical Review • Compounded GLP-1 Safety Guide

Oral Semaglutide

Daily oral GLP-1 option

From $129 Get Started

Semaglutide Injection

Weekly GLP-1 injection

From $129 Get Started

Tirzepatide Tablets

Oral treatment option

From $199 Get Started

Tirzepatide Injection

Weekly dual-action support

From $229 Get Started

One practical way to protect yourself is to understand how to check that your medication is made properly. That is where the Certificate of Analysis (COA) comes in. You do not have to become a chemist to understand it. Even a basic understanding can help you and your healthcare team decide whether a product seems trustworthy and whether a pharmacy is serious about safety.

What Are GLP-1s and Why Are They Used?

GLP-1 receptor agonists (GLP-1 RAs) are medications that act like a natural hormone called GLP-1, which helps control blood sugar and appetite. In simple terms, they:

• Help you feel full sooner and longer
• Slow the movement of food from your stomach
• Help your pancreas release insulin when needed
• Reduce the liver’s release of sugar into the blood

Common brand-name GLP-1 medicines include semaglutide and tirzepatide, used for type 2 diabetes and weight management. Clinical studies show these drugs can lead to meaningful weight loss and better blood sugar control when used along with lifestyle changes.

Patients often describe GLP-1 therapy as a “reset” that helps them manage cravings and portion sizes more easily, especially when combined with support from healthcare teams. For many people, these medications are more than “weight-loss shots”, they are part of long-term treatment for chronic conditions like obesity and diabetes.

Doctor-Guided Care

Explore Personalized GLP-1 Treatment Options

Learn more about oral and injectable GLP-1 therapies with guidance from a patient-centered medical team focused on safety, education, and long-term support.

Start Now

What Does “Compounded GLP-1” Mean?

Compounded medications in plain language

A compounded medication is a drug that a special pharmacy prepares from scratch for an individual person, based on a prescription. This might be done to:

• Adjust the dose to something not sold commercially
• Change the form (for example, liquid instead of tablet)
• Remove certain ingredients like dyes or allergens

Compounding can be very helpful when no standard product fits a patient’s needs. But it is important to know that compounded drugs themselves are not FDA-approved, even if the raw ingredients they use may be. That means the FDA has not reviewed each compounded product for safety, effectiveness, or manufacturing quality before patients receive it.

Why are compounded GLP-1s on the market?

Because of high demand, many areas have seen shortages of brand-name GLP-1 drugs like semaglutide and (previously) tirzepatide. During a true shortage, some pharmacies are allowed to prepare compounded GLP-1 medications to help fill the gap for patients who might otherwise go without treatment.

Compounded GLP-1s are often marketed as:

• More affordable options
• Available when brand products are out of stock
• Convenient “weight-loss injections” from clinics, spas, or online services

However, studies and safety reports have raised concerns about dosing errors, contamination, incorrect strength, and other quality issues with some compounded GLP-1 products. This does not mean all compounded GLP-1s are unsafe, but it does mean you have to be more cautious and informed as a patient.

Safety Concerns with Compounded GLP-1s

Risks that have been reported

Research using the FDA’s adverse event database has found that reports involving compounded GLP-1 drugs show higher odds of:

• Stomach pain, nausea, and diarrhea
• Gallbladder problems such as cholecystitis (inflamed gallbladder)
• Medication preparation and prescribing errors
• Product contamination and compounding/manufacturing problems
• Hospitalization linked to these issues

This same analysis found that compounded products had much higher reporting odds for preparation errors and contamination compared with non-compounded GLP-1s.

The FDA has also received reports of serious side effects and hospitalizations connected to dosing errors with compounded semaglutide products. Many of these cases involve confusion over different strengths, measuring units, and how much to draw into the syringe.

Why quality can vary

Unlike large drug manufacturers, compounding pharmacies do not have to go through the same extensive FDA pre-approval process, clinical trials, or standardized manufacturing checks for each product. Instead, they are expected to follow professional standards and, in some cases, additional regulations if they are registered as “outsourcing facilities.”

Quality can vary based on:

• The pharmacy’s staff training and experience
• The cleanliness and equipment of the facility
• The quality checks they perform (or do not perform)
• Whether they test final products through independent laboratories

Because of these differences, one of the most useful tools to assess quality is the Certificate of Analysis.

What Is a Certificate of Analysis (COA)?

A Certificate of Analysis (COA) is a document from a laboratory that shows test results for a medication batch. You can think of it as a detailed lab “report card” confirming what is in the product and whether it meets certain quality standards.

For compounded GLP-1 medications, a COA usually includes:

• The name of the active ingredient (for example, semaglutide or tirzepatide)
• The strength or concentration (how much medicine is in each mL or dose)
• Results of potency testing (does it contain the right amount of active drug?)
• Results of purity and contamination tests (are there unwanted substances or microbes?)
• Identification of the batch or lot number
• The date of the tests and an expiry or “retest” date
• The name of the lab that performed the testing and sometimes the testing methods

When used properly, a COA helps show that a compounded product has been checked by a lab and meets specified limits for strength and purity. For a patient, this is not about reading every technical detail. It is about knowing that testing has been done and that the results are acceptable.

Why Certificates of Analysis Matter for Patient Safety

Extra protection when there is less oversight

Because compounded GLP-1 products do not go through the standard drug approval process, independent testing and documentation become even more important. A COA helps reduce some of the uncertainty by:

• Confirming the product contains the correct drug and dose
• Showing that contaminants are either not present or below safe levels
• Giving traceable details (lot numbers, dates) if a problem arises later

Scientific reviews of compounded GLP-1 products emphasize that rigorous quality testing and documentation, including COAs, are key to lowering risks.

Early warning for quality problems

When something goes wrong in compounding, for example, wrong strength, impurities, or microbial contamination, it can cause side effects, lack of effect, or serious harm. Studies have documented higher rates of product quality issues and preparation errors with compounded GLP-1s.

A proper COA does not guarantee perfection, but it increases the chances that:

• Problems are caught before the product reaches you
• Batches with poor results are not dispensed
• Your clinic or pharmacy can trace and respond to any safety issue quickly

In other words, a COA is one way that pharmacies can show they are taking patient safety in compound therapies seriously.

How to Read a Certificate of Analysis in Simple Terms

You never need to interpret a COA alone, but having a basic sense of what it means can empower you. Here are the main parts, translated into everyday language.

1. Product identification

Look for:

• Name of the drug: for example, “semaglutide” or “tirzepatide.”
• Form: such as “solution for injection,” “vial,” or “prefilled syringe.”
• Strength: for example, “2.5 mg/mL” or similar.

This should match what your prescription says. If your prescription and the COA show different drugs or strengths, that is a red flag to raise with your provider.

2. Batch or lot number

The lot number on the COA should match the lot number on your medication label. This is how labs, pharmacies, and regulators trace a specific batch if a problem is discovered.

If there is ever a recall or safety alert, this number is what allows your pharmacy or clinic to know if your medication is affected.

3. Potency results

Potency is about how much active drug is actually in the product compared to what it is supposed to have. Results may look like a percentage, for example, “98% of label claim.”

In most pharmaceutical settings, small differences are acceptable, but large differences can mean you are getting too little or too much medicine. For GLP-1s, too much drug can increase the risk of serious side effects, while too little can reduce effectiveness.

4. Purity and impurities

This part looks at whether there are related substances or impurities, including breakdown products.

“Within limits” or within a specified range usually means the impurities are low enough to be considered acceptable.

Abnormal or high levels may suggest poor quality raw material, poor storage, or problems during compounding.

You do not need to understand each impurity name; the key is that the lab has checked for them and judged them acceptable.

5. Microbial testing

Because many compounded GLP-1s are sterile injections, testing for microbes (bacteria, fungi) is vital.

The COA may list tests like:

• “Sterility test”
• “Endotoxin test”

Results should indicate that the sample passed these tests or is “compliant” with standards. Contamination by microbes or toxins can cause serious infections or reactions.

6. Dates and signatures

A reliable COA will show:

• The date of testing
• An expiration or “retest” date
• The name of the testing lab
• Sometimes a signature or electronic approval

These details help show that the testing is recent, traceable, and performed by a recognized laboratory.

If anything on the COA feels unclear or worrying, it is reasonable to ask your pharmacist or prescriber to explain it in plain language.

Patient Education

Understand Your Medication With Confidence

Patients deserve clear answers about compounded GLP-1 medications, dosing, quality testing, and Certificates of Analysis before starting treatment.

Start Now

You have every right to ask questions about a medication you are putting into your body. Healthcare ethics and patient experience research both show that people feel safer and more satisfied when information is shared clearly and honestly.

A trustworthy clinic or pharmacy should be willing to talk with you openly about these topics and explain any technical terms.

If you are considering compounded GLP-1 treatment and want guidance from a clinician who focuses on this area, Doctor Adam may be a helpful resource. At Doctor Adam, patients can learn more about GLP-1 options, get answers to safety and quality questions, and explore whether this type of therapy fits their health goals in a supportive, patient-centered setting.

Signs of a Cautious, Patient-Centered Approach

While no setting is perfect, certain practices suggest that a provider is taking patient safety in compound therapies seriously, especially for compounded GLP-1s:

• They clearly explain whether a product is FDA-approved or compounded, and why they are recommending one or the other.
• They discuss known risks and benefits, including what is still uncertain about compounded GLP-1s.
• They use standardized dosing instructions and check your understanding, especially if you are drawing doses from a vial.
• They monitor you over time, asking about side effects like nausea, abdominal pain, mood changes, or signs of gallbladder issues.
• They can provide or request a Certificate of Analysis for your medication and answer your questions about it.

Patients in qualitative studies often say they value feeling listened to, having their concerns validated, and receiving clear, non-judgmental information about GLP-1 therapy options.

Practical Tips for Patients Using or Considering Compounded GLP-1s

These suggestions are meant as gentle guidance, not strict rules. Everyone’s situation is different, and the best choices are usually made together with your healthcare team.

• Try to understand whether your medicine is a brand-name GLP-1 or a compounded GLP-1 and why that option was chosen.
• If your medicine is compounded, consider asking whether a COA is available for your batch and whether it is tested by an independent lab.
• Ask your prescriber or pharmacist to show you physically how to measure and inject the dose, and repeat it back to confirm you feel comfortable.
• Keep your medication in its original packaging so the lot number and pharmacy information remain available.
• Make a simple note on your phone or in a notebook of when you start therapy, your doses, and any side effects you notice. This makes discussions with your provider easier and more precise.
• If at any point you feel unsure or uneasy, it is okay to pause and ask more questions before taking the next dose. Feeling safe and informed is part of good care.

It Is Normal to Have Mixed Feelings

Many people seeking GLP-1 therapy for obesity or diabetes have already been through years of trying diets, exercise plans, and sometimes facing stigma or misunderstanding. Studies on patient experiences with GLP-1 medicines highlight feelings of hope, fear of side effects, worries about long-term safety, and frustration around access and cost.

If you are considering a compounded GLP-1, you might be thinking:

• “I finally found something that works; I do not want to lose it.”
• “I am scared of making a mistake with the dose.”
• “I want to be safe but I also do not want to go backwards with my health.”

All of these feelings are valid. Wanting more information about Certificates of Analysis and safety is not being “difficult”; it is being an engaged, thoughtful partner in your own care. Healthcare teams that understand this will usually welcome your questions.

When Might a Compounded GLP-1 Be Reasonable to Consider?

Expert commentary and regulatory guidance generally suggest that compounded medications should be used when patients have needs that cannot be met by an FDA-approved product, such as during true shortages, unique dosing needs, or allergies to certain ingredients.

Some situations where a compounded GLP-1 might be considered include:

• A documented shortage of the FDA-approved product in your region, and no reasonable alternatives available
• A need for a non-standard dose or formulation that is not commercially available, discussed carefully with your specialist
• After thorough conversation about the added risks and uncertainties, with a plan for close monitoring

Even in these cases, quality safeguards like COAs, careful dosing education, and regular follow-up become especially important.

Conclusion

Compounded GLP-1 medications can offer an option for people who face barriers to accessing brand-name drugs, but it is completely understandable to want strong reassurance about safety and quality along the way. Certificates of Analysis and other quality documents cannot replace FDA approval or personalized medical advice, but they can help show that important checks—such as identity, purity, and potency testing—have been performed and recorded.

Patients do not need to understand every technical detail on a COA to ask meaningful questions or to advocate for their own safety. Often, the most powerful steps are simply to ask whether testing information is available, to confirm that preparation and storage standards are followed, and to keep open communication with the healthcare team. Over time, this combination of clear information, thoughtful questions, and ongoing follow-up can support more confident, informed decisions about whether compounded GLP-1 treatment feels right for each individual person.

Frequently Asked Questions

Medically Reviewed by Jaclyn P. Leyson-Azuela, RMT, MD, MPH

Jaclyn P. Leyson-Azuela, RMT, MD, MPH, is a physician, medical writer, and researcher with a strong background in public health, clinical medicine, and academic instruction. She has served as an Assistant Professor teaching core medical sciences, a Doctor-to-the-Barrio delivering frontline care in underserved communities, and a COVID-19 facility manager during the pandemic.